Frontera Therapeutics (FRONT HK): Synthetic Expert Call Transcript (31 Aug 2026)
Hong Kong IPO Urgency & Runway Risk: Frontera’s resubmitted listing application on August 28, 2026 (following the lapse of its December 2025...
107 Views
IPO Databook: Frontera Therapeutics (HK) - Aug 2026
Incorporated in 2019, Frontera Therapeutics is a clinical-stage gene therapy company developing rAAV gene therapies for ophthalmic and...
97 Views
Pre-IPO Frontera Therapeutics - The Promising Gene Therapy Pipeline and the Concerns Behind
​Frontera focuses on ophthalmology and cardiovascular diseases, boasting mature paths of cost reduction for rAAV. Due to risks on R&D...
256 Views
Frontera Pre-IPO: Emerging Ophthalmic Gene Therapy Player with a Catch
​China-based biotech company Frontera aims to raise $100 million through Hong Kong listing. We look at its core products FT-003 and FT-002, pre-IPO...
446 Views
Aequitas: ECM Weekly (12 January 2026) - Biren, MiniMax, Gigadevice, Omnivision, Busy Ming, HPSP, GF
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
506 Views
No more insights